AIM ImmunoTech Inc. (AIM), an immuno-pharma company, on Monday announced that the company had regained compliance with NYSE American for the minimum requirement in stockholders' equity established for a continued listing.
The company previously received notice from the NYSE American that it was in violation of a listing rule pertaining to the minimal stockholders' equity required, and the 'Below Compliance' (.BC) indicator was added to the company's trading symbol on the NYSE.
Accordingly, the company entered into a warrant exercise inducement offer letter agreement with holders of existing warrants on May 7, 2026. This resulted in gross proceeds of $3.5 million after exercising the warrants.
On May 21, 2026, the company issued 7,519,351 shares of common stock, and in a concurrent private placement, Class I warrants to purchase up to 15,038,702 shares of common stock to investors for aggregate gross proceeds of $2.4 million.
Furthermore, on June 10, 2026, the company issued and sold 2,554,119 shares of common stock and, in a concurrent private placement, 771,503 shares of common stock, pre-funded warrants to purchase up to 1,782,616 shares of common stock, and Class J warrants to purchase up to 10,216,476 shares of common stock to investors for aggregate gross proceeds of approximately $2.6 million.
Following the closing of these transactions, the company reportedly has stockholders' equity in excess of the $6.0 million minimum requirement. On June 12, 2026, the company received formal notification from NYSE American stating that it had regained compliance.
AIM closed Monday at $0.38, down 4.39%. In the pre-market, shares are trading at $0.39, up 0.39%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.